Try it
Pharmacology · Endocrine drugs: sapropterin in phenylketonuria
Sample itemA subset of patients with phenylketonuria who have residual phenylalanine hydroxylase activity improve on an oral synthetic preparation of a cofactor. Which cofactor is it?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Tetrahydrobiopterin
Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), the cofactor of phenylalanine hydroxylase. In patients with residual enzyme activity it enhances activity and lowers blood phenylalanine, allowing more dietary protein. A low phenylalanine diet remains the cornerstone.
Option by option
A. Thiamine pyrophosphate
Thiamine pyrophosphate is a cofactor for pyruvate dehydrogenase and transketolase.
B. Pyridoxal phosphate
Pyridoxal phosphate is a cofactor for transaminases and decarboxylases, not phenylalanine hydroxylase.
C. Tetrahydrobiopterin (correct)
Correct. Sapropterin is tetrahydrobiopterin, the cofactor of phenylalanine hydroxylase.
D. Biotin
Biotin is a carboxylase cofactor.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?